Elaine T Lam

9PUBLICATIONS
39CO-AUTHORS
Molecular targetsPredictive and prognostic markersSolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 21, 2026
Tyrosine kinase inhibitors affect sweet taste and dysregulate fate selection of specific taste bud cell subtypes via KIT inhibition.

|May 25, 2024
Clinical and Genomic Features of Patients with Renal Cell Carcinoma and Advanced Chronic Kidney Disease: Analysis of a Multi-Institutional Database.

Corbin J Eule, Junxiao Hu, Dale Hedges

|Apr 27, 2024
A Phase Ib Expansion Cohort Evaluating Aurora A Kinase Inhibitor Alisertib and Dual TORC1/2 Inhibitor Sapanisertib in Patients with Advanced Solid Tumors.

S Lindsey Davis, Wells A Messersmith, W Thomas Purcell

|Apr 23, 2024
A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2α in Patients with Advanced Clear Cell Renal Cell Carcinoma.

James Brugarolas, Gregory Obara, Kathryn E Beckermann

|Dec 21, 2023
Use of Peripheral Intravenous Access in Patients Undergoing Chemotherapy for Testicular Cancer.

Brett Wiesen, Michael Atwell, Colton Leavitt

|Jun 28, 2023
A Phase I/II Clinical Trial of Pembrolizumab and Cabozantinib in Metastatic Renal Cell Carcinoma.

Elizabeth R Kessler, Eryn Callihan, Junxiao Hu

Pageof 2

Frequent Collaborators

3 joint publications

Thomas W Flaig

3 joint publications

Corbin J Eule

2 joint publications

Elizabeth R Kessler

2 joint publications

Junxiao Hu